CHI Advisors’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $35.8M | Sell |
2,966,674
-32,060
| -1% | -$387K | 14.2% | 2 |
|
|
2023
Q2 | $31.7M | Buy |
2,998,734
+795
| +0% | +$8.41K | 9.63% | 5 |
|
|
2023
Q1 | $29.5M | Buy |
2,997,939
+197,813
| +7% | +$1.95M | 7.83% | 5 |
|
|
2022
Q4 | $41.2M | Sell |
2,800,126
-269,721
| -9% | -$3.97M | 10.97% | 4 |
|
|
2022
Q3 | $37.2M | Buy |
3,069,847
+423,066
| +16% | +$5.13M | 10.01% | 4 |
|
|
2022
Q2 | $37M | Buy |
2,646,781
+65,684
| +3% | +$919K | 14.14% | 3 |
|
|
2022
Q1 | $36.8M | Buy |
2,581,097
+368,841
| +17% | +$5.25M | 15.63% | 2 |
|
|
2021
Q4 | $46.7M | Sell |
2,212,256
-20,527
| -0.9% | -$433K | 15.49% | 2 |
|
|
2021
Q3 | $58.6M | Sell |
2,232,783
-306,861
| -12% | -$8.05M | 17.1% | 2 |
|
|
2021
Q2 | $79.2M | Sell |
2,539,644
-21,059
| -0.8% | -$657K | 18.42% | 1 |
|
|
2021
Q1 | $78.6M | Buy |
2,560,703
+28,553
| +1% | +$876K | 15.73% | 3 |
|
|
2020
Q4 | $86.9M | Buy |
2,532,150
+1,656
| +0.1% | +$56.8K | 24.47% | 1 |
|
|
2020
Q3 | $77.9M | Buy |
2,530,494
+27,086
| +1% | +$833K | 27.7% | 1 |
|
|
2020
Q2 | $77.7M | Buy |
+2,503,408
| New | +$77.7M | 30.3% | 1 |
|